drugset
drugset / Trial / NCT00442897

Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)

NCT00442897 ↗

Phase 4 Completed 229 enrolled Organon and Co
RandomizedParallel-groupOpen-labelTreatment

Summary

Evaluate the proportion of hyperlipaemic persons with known coronary heart disease achieving ldl-c goal as defined by the national cholesterol education program (NCEP) adult treatment panel (ATP) III guidelines

Timeline

Start
2006-09
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 10 mg Oral
Subject Ezetimibe Unknown 20 mg Oral
Subject Simvastatin Small molecule 10 mg Oral

Indications

hyperlipidemia